8,898 reports of this reaction
2.8% of all INTERFERON BETA 1A reports
#6 most reported adverse reaction
GAIT DISTURBANCE is the #6 most commonly reported adverse reaction for INTERFERON BETA 1A, manufactured by Biogen Inc.. There are 8,898 FDA adverse event reports linking INTERFERON BETA 1A to GAIT DISTURBANCE. This represents approximately 2.8% of all 322,666 adverse event reports for this drug.
Patients taking INTERFERON BETA 1A who experience gait disturbance should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
GAIT DISTURBANCE is a less commonly reported adverse event for INTERFERON BETA 1A, but still significant enough to appear in the safety profile.
In addition to gait disturbance, the following adverse reactions have been reported for INTERFERON BETA 1A:
The following drugs have also been linked to gait disturbance in FDA adverse event reports:
GAIT DISTURBANCE has been reported as an adverse event in 8,898 FDA reports for INTERFERON BETA 1A. This does not prove causation, but indicates an association observed in post-market surveillance data.
GAIT DISTURBANCE accounts for approximately 2.8% of all adverse event reports for INTERFERON BETA 1A, making it a notable side effect.
If you experience gait disturbance while taking INTERFERON BETA 1A, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.